Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 28, 2015 8:37 PM ET

Healthcare Providers and Services

Company Overview of Genoptix, Inc.

Company Overview

Genoptix, Inc. provides oncology diagnostics and informatics services in the United States. It operates hematopathology centers that provide community oncologists and pathologists with comprehensive testing solutions in hematology and solid tumor molecular profiling. The company’s solutions include COMPASS, a comprehensive diagnostic approach for hematomalignancies; molecular profiles for myeloid malignancies, myelodysplastic syndromes, and acute myeloid leukemia in Heme, as well as melanoma for skin cancer; and NexCourse breast diagnostic services, including traditional FISH and immunohistochemistry, as well as IHC testing. It also offers customized clinical trial services, custom assay dev...

1811 Aston Avenue

Carlsbad, CA 92008

United States

Founded in 1999

508 Employees

Phone:

760-268-6200

Fax:

760-268-6201

Key Executives for Genoptix, Inc.

Chief Financial Officer, Principal Accounting Officer and Executive Vice President
Age: 54
President of Cartesian Medical Group and Chief Medical Officer of Cartesian Medical Group
Age: 55
Chief Compliance Officer, Vice President, Corporate Secretary and General Counsel
Age: 41
Chief Information Officer and Senior Vice President
Age: 51
Senior Vice President of Commercial Operations
Age: 53
Compensation as of Fiscal Year 2014.

Genoptix, Inc. Key Developments

Genoptix Inc. Settles Shareholder Suit Filed in 2010 for $7.7 Million

Genoptix Inc. announced that it will resolve a shareholder lawsuit originally filed in 2010 for $7.7 million. According to the lawsuit, Genoptix misled investors about the consumer demand for its product-diagnostic testing services that analyzed blood and bone marrow samples for diseases-including negative sales trends unique to the company. The complaint alleged the misrepresentations resulted in an inflated stock value that cost investors money. The suit was filed on behalf of all persons who purchased stock in Genoptix between July 31, 2009, and June 16, 2010. The parties to the case filed a request for preliminary approval of the settlement.

Similar Private Companies By Industry

Company Name Region
Carraway Medical Systems LLC United States
Delta Dental Of New York Inc. United States
Saint Luke's North Hospital United States
Grey Healthcare Group, Inc. United States
Bariatric Partners, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Genoptix, Inc., please visit www.genoptix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.